232 related articles for article (PubMed ID: 8211781)
21. [Myelodysplastic syndromes and refractory anemias with reference to the erythropoietic abnormalities].
Yoshida Y
Nihon Rinsho; 1991 Mar; 49(3):587-92. PubMed ID: 2041184
[No Abstract] [Full Text] [Related]
22. [Refractory anemia and preleukemia: an analysis of 92 cases].
Xu K; Hao Y
Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):65-8. PubMed ID: 11601200
[TBL] [Abstract][Full Text] [Related]
23. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
Verbeek W; Vehmeyer K; Wörmann B; Hiddemann W
J Cancer Res Clin Oncol; 1995; 121(6):338-42. PubMed ID: 7797598
[TBL] [Abstract][Full Text] [Related]
24. [The concept of and countermeasures in refractory anemia].
Yoshida Y
Nihon Naika Gakkai Zasshi; 1990 May; 79(5):593-7. PubMed ID: 2199586
[No Abstract] [Full Text] [Related]
25. Pathologic sideroblastosis in myelodysplastic syndromes and acute nonlymphocytic leukemia.
Bernardeschi P; Bonechi I
Recenti Prog Med; 1991 Nov; 82(11):588-90. PubMed ID: 1763231
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005).
Weiss DJ
J Am Vet Med Assoc; 2006 Mar; 228(6):893-7. PubMed ID: 16536701
[TBL] [Abstract][Full Text] [Related]
27. Ringed sideroblasts in primary myelodysplasia. Leukemic propensity and prognostic factors.
Vandermolen L; Rice L; Rose MA; Lynch EC
Arch Intern Med; 1988 Mar; 148(3):653-6. PubMed ID: 3341866
[TBL] [Abstract][Full Text] [Related]
28. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
[TBL] [Abstract][Full Text] [Related]
31. [Erythropoiesis in myelodysplastic syndrome detected by multiparameter flow cytometry].
Jensen IM; Jensen PD; Hokland ME; Hokland P; Ellegaard J
Ugeskr Laeger; 1995 Sep; 157(37):5092-6. PubMed ID: 7502376
[TBL] [Abstract][Full Text] [Related]
32. The natural history of trilinear myelodysplastic syndrome and erythroleukemia.
Michiels JJ; van der Meulen J; Brederoo P
Haematologica; 1997; 82(4):452-54. PubMed ID: 9299860
[TBL] [Abstract][Full Text] [Related]
33. Primary myelodysplastic syndrome in Jordan: a single-centre experience.
Awidi A; Magableh A; Taimeh Z; Ayyad H; Bsoul N; Tarawneh M
Med Princ Pract; 2009; 18(5):351-5. PubMed ID: 19648755
[TBL] [Abstract][Full Text] [Related]
34. Clinico-haematological characteristics in Pakistani patients of primary myelodysplastic syndrome according to World Health Organization classification.
Ehsan A; Aziz M
J Coll Physicians Surg Pak; 2010 Apr; 20(4):232-6. PubMed ID: 20392397
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
Cazzola M; Invernizzi R; Bergamaschi G; Levi S; Corsi B; Travaglino E; Rolandi V; Biasiotto G; Drysdale J; Arosio P
Blood; 2003 Mar; 101(5):1996-2000. PubMed ID: 12406866
[TBL] [Abstract][Full Text] [Related]
36. Myelodysplastic syndrome with erythroid hypoplasia: a rare and distinct clincopathological entity--a report of two cases.
Kumar V; Dash S
Indian J Pathol Microbiol; 2005 Jan; 48(1):36-7. PubMed ID: 16758786
[TBL] [Abstract][Full Text] [Related]
37. [Clinical features of atypical refractory anemia (RA)].
Matsuda A; Jinnai I; Kusumoto S; Shiramatsu F; Bessho M; Saito M; Hirashima K
Rinsho Ketsueki; 1991 Aug; 32(8):855-61. PubMed ID: 1942525
[TBL] [Abstract][Full Text] [Related]
38. The soluble transferrin receptor in dysplastic erythropoiesis in myelodysplastic syndrome.
Metzgeroth G; Rosée PL; Kuhn C; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
Eur J Haematol; 2007 Jul; 79(1):8-16. PubMed ID: 17532764
[TBL] [Abstract][Full Text] [Related]
39. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
[TBL] [Abstract][Full Text] [Related]
40. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.
Vasef MA; Murata-Collins JL; Alsabeh R; Medeiros LJ
Arch Pathol Lab Med; 1998 Jan; 122(1):77-83. PubMed ID: 9448022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
